FY2025 EPS Estimates for NBIX Decreased by Cantor Fitzgerald
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Equities researchers at Cantor Fitzgerald dropped their FY2025 EPS estimates for shares of Neurocrine Biosciences in a note issued to investors on Friday, April 25th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will earn $4.20 per share for the year, down from their prior […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Equities researchers at Cantor Fitzgerald dropped their FY2025 EPS estimates for shares of Neurocrine Biosciences in a note issued to investors on Friday, April 25th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will earn $4.20 per share for the year, down from their prior […]
